Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

Sam-A Pharm. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9,387	9,551	9,019	9,176	7,984	18,396
Short-Term Investments	43,641	48,638	61,638	68,638	45,638	29,911
Trading Asset Securities	35,285	18,474	8,447	3,197	-	16,048
Cash & Short-Term Investments	88,314	76,664	79,104	81,011	53,623	64,354
Cash Growth	18.52%	-3.08%	-2.35%	51.08%	-16.68%	28.90%
Accounts Receivable	16,489	19,060	22,596	21,466	18,039	15,418
Other Receivables	2,308	2,794	3,079	2,025	1,293	1,878
Receivables	18,797	21,854	25,675	23,491	19,332	17,296
Inventory	17,880	14,283	13,013	12,244	9,341	12,157
Prepaid Expenses	-	135.22	160.76	71.14	44.88	47.44
Other Current Assets	270.37	153.46	38.37	40.27	13.96	11.46
Total Current Assets	125,261	113,089	117,992	116,856	82,355	93,866
Property, Plant & Equipment	40,636	42,750	40,511	37,164	40,188	43,412
Long-Term Investments	62,102	71,939	61,362	42,957	60,434	36,951
Other Intangible Assets	4,766	4,189	4,295	4,394	5,537	6,276
Long-Term Deferred Tax Assets	201.63	519.39	80.27	1,041	-	578.59
Other Long-Term Assets	6,855	6,819	7,067	786.49	657.77	1,024
Total Assets	248,825	248,734	231,308	203,198	189,172	182,106
Accounts Payable	4,908	5,830	5,002	7,040	3,772	2,562
Accrued Expenses	-	907.14	2,229	1,745	15.74	11.05
Current Portion of Long-Term Debt	4,556	4,556	1,667	-	2,407	-
Current Portion of Leases	1,786	1,835	1,858	1,725	1,709	1,783
Current Income Taxes Payable	2,784	3,721	3,542	4,386	1,580	348.9
Other Current Liabilities	5,208	3,659	6,847	6,662	5,111	4,762
Total Current Liabilities	19,241	20,508	21,145	21,558	14,594	9,468
Long-Term Debt	-	2,278	2,500	-	-	2,407
Long-Term Leases	3,565	4,221	5,645	45	1,509	3,015
Long-Term Deferred Tax Liabilities	-	18.24	12.05	12.05	175.08	-
Other Long-Term Liabilities	1,911	1,650	1,536	964.81	868.76	917.34
Total Liabilities	24,834	28,758	30,838	22,580	17,147	15,819
Common Stock	6,370	6,370	6,370	6,370	6,370	6,370
Additional Paid-In Capital	14,413	14,413	14,413	14,413	14,413	14,413
Retained Earnings	200,575	196,482	179,204	160,354	149,836	147,812
Treasury Stock	-1,513	-1,513	-1,513	-1,513	-1,513	-1,513
Comprehensive Income & Other	4,145	4,223	1,996	992.92	2,917	-795.91
Shareholders' Equity	223,991	219,976	200,470	180,618	172,024	166,287
Total Liabilities & Equity	248,825	248,734	231,308	203,198	189,172	182,106
Total Debt	9,906	12,890	11,669	1,770	5,625	7,206
Net Cash (Debt)	78,408	63,774	67,435	79,241	47,998	57,148
Net Cash Growth	25.16%	-5.43%	-14.90%	65.09%	-16.01%	37.89%
Net Cash Per Share	12847.11	10449.02	11048.85	12983.19	7864.24	9363.43
Filing Date Shares Outstanding	6.1	6.1	6.1	6.1	6.1	6.1
Total Common Shares Outstanding	6.1	6.1	6.1	6.1	6.1	6.1
Working Capital	106,020	92,581	96,848	95,298	67,761	84,398
Book Value Per Share	36699.70	36041.86	32845.97	29593.28	28185.26	27245.20
Tangible Book Value	219,225	215,787	196,175	176,224	166,488	160,011
Tangible Book Value Per Share	35918.84	35355.57	32142.19	28873.32	27278.10	26216.95
Land	-	4,346	4,346	9,343	9,343	9,343
Buildings	-	30,472	30,472	30,445	30,445	30,445
Machinery	-	29,435	24,791	23,856	24,141	23,879
Construction In Progress	-	1,836	1,174	45.73	4.03	4.03

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.